Aveanna Healthcare Holdings Inc. (AVAH) surged 5.03% intraday as multiple analysts raised their price targets for the stock, signaling improved market sentiment.
UBS increased its price target to $10 from $9.50 while maintaining a Neutral rating, while RBC Capital raised its target to $11 from $10 and kept a Sector Perform rating. These adjustments reflect growing optimism about the company's prospects among Wall Street analysts.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.